SR

Sorrento Therapeutics

- NASDAQ:SRNE
Last Updated 2024-05-07
  • Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

  • Locations

    • San Diego CA

  • Total Funding (USD)

    152.3 million

  • Industries

    Real Estate, Mobile Apps, Internet, Cyber Security

  • Security

    Type: ORD
    CUSIP: 83587F202
    ISIN: US83587F2020
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo